Molecular Oncology is an Open Access journal with no subscribers. A fee is payable by the author or research funder to cover the costs associated with publication. This ensures each article will be immediately and permanently free for anyone to access. The Open Access publication fee for this journal is $3000, excluding taxes. Authors will be asked to pay the article publication charge on acceptance of their article.
Your institute or funder may have an agreement with Wiley to pay all or some of the article publication charge on your behalf. You can check here. Waivers and discounts are available to authors from countries eligible for the Research4Life programs. You can check the lists of countries here.
All Molecular Oncology articles are now published under the terms of the Creative Commons Attribution License (CC BY)* which allows users to copy, distribute and transmit an article, to adapt the article and to make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
Use of the article, in whole or part, in any medium requires attribution suitable in form and content as follows: [Title of Article/Author/Journal Title and Volume/Issue]. Published under a Creative Commons Attribution (CC BY) License.
Links to the final article on Wiley’s website are encouraged where applicable.
* Please note that all articles published in Volumes 1-10 were published under the agreement as stated in the final article.
Journal Special Features
From January 1, 2017 Molecular Oncology is published by FEBS Press and Wiley
Molecular Oncology has become fully Open Access, allowing everyone to read the journal irrespective of speciality, host institution or location. All articles are published under the Creative Commons Attribution License (CC BY) to meet funders’ requirements worldwide.
- 2016 2-Year Impact Factor: 5.314
- 2016 5-Year Impact Factor: 5.957
- 2016 CiteScore: 5.25
Editor-in-Chief Julio Celis
Managing Editor Jose Moreira
Future Events in Oncology
- 4th EACR conference on A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments
- 2nd EACR conference on Radiation Break-through: from DNA damage responses to precision cancer therapy